1887

Abstract

Vaccinia virus (VACV) strain Western Reserve gene encodes a small intracellular protein with a Bcl-2 fold that is expressed early during infection and has multiple functions. A49 co-precipitates with the E3 ubiquitin ligase β-TrCP and thereby prevents ubiquitylation and proteasomal degradation of IκBα, and consequently blocks activation of NF-κB. In a similar way, A49 stabilizes β-catenin, leading to activation of the wnt signalling pathway. However, a VACV strain expressing a mutant A49 that neither co-precipitates with β-TrCP nor inhibits NF-κB activation, is more virulent than a virus lacking A49, indicating that A49 has another function that also contributes to virulence. Here we demonstrate that gene encodes a second, smaller polypeptide that is expressed via leaky scanning translation from methionine 20 and is unable to block NF-κB activation. Viruses engineered to express either only the large protein or only the small A49 protein both have lower virulence than wild-type virus and greater virulence than an deletion mutant. This demonstrates that the small protein contributes to virulence by an unknown mechanism that is independent of NF-κB inhibition. Despite having a large genome with about 200 genes, this study illustrates how VACV makes efficient use of its coding potential and from gene expresses a protein with multiple functions and multiple proteins with different functions.

Funding
This study was supported by the:
  • Geoffrey L. Smith , Wellcome Trust , (Award 090315)
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001386
2020-02-25
2020-06-02
Loading full text...

Full text loading...

/deliver/fulltext/jgv/101/5/533.html?itemId=/content/journal/jgv/10.1099/jgv.0.001386&mimeType=html&fmt=ahah

References

  1. Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP et al. The complete DNA sequence of vaccinia virus. Virology 1990; 179:247–266 [CrossRef][PubMed]
    [Google Scholar]
  2. Moss B. Poxviridae. In Knipe DMH. editor Fields Virology Philadelphia: Lippincott Williams & Wilkins; 2013 pp 2129–2159
    [Google Scholar]
  3. Smith GL, Benfield CTO, Maluquer de Motes C, Mazzon M, Ember SWJ et al. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 2013; 94:2367–2392 [CrossRef][PubMed]
    [Google Scholar]
  4. Mansur DS, Maluquer de Motes C, Unterholzner L, Sumner RP, Ferguson BJ et al. Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog 2013; 9:e1003183 [CrossRef][PubMed]
    [Google Scholar]
  5. Neidel S, Maluquer de Motes C, Mansur DS, Strnadova P, Smith GL et al. Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family. J Biol Chem 2015; 290:5991–6002 [CrossRef][PubMed]
    [Google Scholar]
  6. Kvansakul M, van Delft MF, Lee EF, Gulbis JM, Fairlie WD et al. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic bax and bak. Mol Cell 2007; 25:933–942 [CrossRef][PubMed]
    [Google Scholar]
  7. Maluquer de Motes C, Smith GL. Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase β-TrCP. J Gen Virol 2017; 98:3086–3092 [CrossRef][PubMed]
    [Google Scholar]
  8. Neidel S, Ren H, Torres AA, Smith GL. NF-κB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-κB activation. Proc Natl Acad Sci U S A 2019; 116:5699–5704 [CrossRef]
    [Google Scholar]
  9. Falkner FG, Moss B. Transient dominant selection of recombinant vaccinia viruses. J Virol 1990; 64:3108–3111 [CrossRef]
    [Google Scholar]
  10. Parkinson JE, Smith GL. Vaccinia virus gene A36R encodes a Mr 43-50 K protein on the surface of extracellular enveloped virus. Virology 1994; 204:376–390 [CrossRef]
    [Google Scholar]
  11. Alcami A, Smith GL. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 1992; 71:153–167 [CrossRef]
    [Google Scholar]
  12. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 1986; 44:283–292 [CrossRef]
    [Google Scholar]
  13. Cooray S, Bahar MW, Abrescia NGA, McVey CE, Bartlett NW et al. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 2007; 88:1656–1666 [CrossRef]
    [Google Scholar]
  14. Graham SC, Bahar MW, Cooray S, Chen RA-J, Whalen DM et al. Vaccinia virus proteins A52 and B14 share a Bcl-2-like fold but have evolved to inhibit NF-κB rather than apoptosis. PLoS Pathog 2008; 4:e1000128 [CrossRef][PubMed]
    [Google Scholar]
  15. Maluquer de Motes C, Cooray S, Ren H, Almeida GMF, McGourty K et al. Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog 2011; 7:e1002430 [CrossRef][PubMed]
    [Google Scholar]
  16. Kvansakul M, Yang H, Fairlie WD, Czabotar PE, Fischer SF et al. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands. Cell Death Differ 2008; 15:1564–1571 [CrossRef]
    [Google Scholar]
  17. Wasilenko ST, Banadyga L, Bond D, Barry M. The vaccinia virus F1L protein interacts with the proapoptotic protein bak and inhibits bak activation. J Virol 2005; 79:14031–14043 [CrossRef][PubMed]
    [Google Scholar]
  18. Gerlic M, Faustin B, Postigo A, Yu EC-W, Proell M et al. Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci U S A 2013; 110:7808–7813 [CrossRef][PubMed]
    [Google Scholar]
  19. Chen RA-J, Ryzhakov G, Cooray S, Randow F, Smith GL. Inhibition of IκB kinase by vaccinia virus virulence factor B14. PLoS Pathog 2008; 4:e22 [CrossRef][PubMed]
    [Google Scholar]
  20. Benfield CTO, Ren H, Lucas SJ, Bahsoun B, Smith GL. Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol 2013; 94:1647–1657 [CrossRef][PubMed]
    [Google Scholar]
  21. Kalverda AP, Thompson GS, Vogel A, Schröder M, Bowie AG et al. Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J Mol Biol 2009; 385:843–853 [CrossRef][PubMed]
    [Google Scholar]
  22. Schröder M, Baran M, Bowie AG. Viral targeting of dead box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. Embo J 2008; 27:2147–2157 [CrossRef][PubMed]
    [Google Scholar]
  23. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc Natl Acad Sci U S A 2000; 97:10162–10167 [CrossRef][PubMed]
    [Google Scholar]
  24. Fedosyuk S, Bezerra GA, Radakovics K, Smith TK, Sammito M et al. Vaccinia virus immunomodulator A46: a lipid and protein-binding scaffold for sequestering host TIR-domain proteins. PLoS Pathog 2016; 12:e1006079 [CrossRef][PubMed]
    [Google Scholar]
  25. Fedosyuk S, Grishkovskaya I, de Almeida Ribeiro E, Skern T. Characterization and structure of the vaccinia virus NF-κB antagonist A46. J Biol Chem 2014; 289:3749–3762 [CrossRef][PubMed]
    [Google Scholar]
  26. Stack J, Bowie AG. Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions. J Biol Chem 2012; 287:22672–22682 [CrossRef][PubMed]
    [Google Scholar]
  27. Stack J, Haga IR, Schröder M, Bartlett NW, Maloney G et al. Vaccinia virus protein A46R targets multiple toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 2005; 201:1007–1018 [CrossRef][PubMed]
    [Google Scholar]
  28. Unterholzner L, Sumner RP, Baran M, Ren H, Mansur DS et al. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 2011; 7:e1002247 [CrossRef][PubMed]
    [Google Scholar]
  29. Stuart JH, Sumner RP, Lu Y, Snowden JS, Smith GL. Vaccinia virus protein C6 inhibits type I IFN signalling in the nucleus and binds to the transactivation domain of STAT2. PLoS Pathog 2016; 12:e1005955 [CrossRef][PubMed]
    [Google Scholar]
  30. Lu Y, Stuart JH, Talbot-Cooper C, Agrawal-Singh S, Huntly B et al. Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6. Proc Natl Acad Sci U S A 2019; 116:11997–12006 [CrossRef][PubMed]
    [Google Scholar]
  31. Soday L, Lu Y, Albarnaz JD, Davies CTR, Antrobus R et al. Quantitative temporal proteomic analysis of vaccinia virus infection reveals regulation of histone deacetylases by an interferon antagonist. Cell Rep 2019; 27:1920–1933 [CrossRef][PubMed]
    [Google Scholar]
  32. Chang HW, Watson JC, Jacobs BL. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A 1992; 89:4825–4829 [CrossRef][PubMed]
    [Google Scholar]
  33. Rivas C, Gil J, Mĕlková Z, Esteban M, Díaz-Guerra M. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 1998; 243:406–414 [CrossRef][PubMed]
    [Google Scholar]
  34. Kwon J-A, Rich A. Biological function of the vaccinia virus Z-DNA-binding protein E3L: gene transactivation and antiapoptotic activity in HeLa cells. Proc Natl Acad Sci U S A 2005; 102:12759–12764 [CrossRef][PubMed]
    [Google Scholar]
  35. Koehler H, Cotsmire S, Langland J, Kibler KV, Kalman D et al. Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3. Proc Natl Acad Sci U S A 2017; 114:11506–11511 [CrossRef][PubMed]
    [Google Scholar]
  36. Brandt TA, Jacobs BL. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol 2001; 75:850–856 [CrossRef][PubMed]
    [Google Scholar]
  37. Peters NE, Ferguson BJ, Mazzon M, Fahy AS, Krysztofinska E et al. A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 2013; 9:e1003649 [CrossRef]
    [Google Scholar]
  38. Mazzon M, Peters NE, Loenarz C, Krysztofinska EM, Ember SWJ et al. A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A 2013; 110:12444–12449 [CrossRef]
    [Google Scholar]
  39. Mazzon M, Castro C, Roberts LD, Griffin JL, Smith GL. A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism. J Gen Virol 2015; 96:395–407 [CrossRef][PubMed]
    [Google Scholar]
  40. Ember SWJ, Ren H, Ferguson BJ, Smith GL. Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol 2012; 93:2098–2108 [CrossRef][PubMed]
    [Google Scholar]
  41. Scutts SR, Ember SW, Ren H, Ye C, Lovejoy CA et al. Dna-Pk is targeted by multiple vaccinia virus proteins to inhibit DNA sensing. Cell Rep 2018; 25:1953–1965 [CrossRef][PubMed]
    [Google Scholar]
  42. Gao C, Pallett MA, Croll TI, Smith GL, Graham SC. Molecular basis of cullin-3 (Cul3) ubiquitin ligase subversion by vaccinia virus protein A55. J Biol Chem 2019; 294:6416–6429 [CrossRef][PubMed]
    [Google Scholar]
  43. Pallett MA, Ren H, Zhang R-Y, Scutts SR, Gonzalez L et al. Vaccinia virus BBK E3 ligase adaptor A55 targets importin-dependent NF-κB activation and inhibits CD8 + T-cell memory. J Virol 2019; 93: [CrossRef]
    [Google Scholar]
  44. Alejo A, Ruiz-Argüello MB, Ho Y, Smith VP, Saraiva M et al. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A 2006; 103:5995–6000 [CrossRef][PubMed]
    [Google Scholar]
  45. Yuwen H, Cox JH, Yewdell JW, Bennink JR, Moss B. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 1993; 195:732–744 [CrossRef][PubMed]
    [Google Scholar]
  46. Yang Z, Cao S, Martens CA, Porcella SF, Xie Z et al. Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling. J Virol 2015; 89:6874–6886 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001386
Loading
/content/journal/jgv/10.1099/jgv.0.001386
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error